Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Schall

Showing results (71-80 of 89) with videos related to

Pageof 9
Sort By:
Biopharmaceutics & Drug Disposition|August 1, 1994
Relative bioavailability of four controlled-release nifedipine productsR Schall, F O Müller, H K Hundt, et al.
Medicine and Science in Sports and Exercise|April 1, 1991
Metabolic rate, not percent dehydration, predicts rectal temperature in marathon runnersT D Noakes, K H Myburgh, J du Plessis, et al.
International Journal of Clinical Pharmacology and Therapeutics|May 1, 1995
No influence of pantoprazole on the pharmacokinetics of phenytoinM V Middle, F O Müller, R Schall, et al.
British Journal of Clinical Pharmacology|June 1, 1995
Lack of effect of pantoprazole on the pharmacodynamics and pharmacokinetics of warfarinL Duursema, F O Müller, R Schall, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 30, 2016
A world-wide survey and field study in clinical haemostasis laboratories to evaluate FVIII:C activity assay variability of ADYNOVATE and OBIZUR in comparison with ADVATEP L Turecek, S Romeder-Finger, C Apostol, et al.
International Journal of Clinical Pharmacology and Therapeutics|May 1, 1996
No influence of pantoprazole on the pharmacokinetics of phenytoinM V Middle, F O Müller, R Schall, et al.
Arzneimittel-Forschung|November 1, 1995
Relative bioavailability of rifampicin, isoniazid and ethambutol from a combination tablet vs. concomitant administration of a capsule containing rifampicin and a tablet containing isoniazid and ethambutolR Schall, F O Müller, L Duursema, et al.
Thrombosis and Haemostasis|December 20, 1993
Antithrombotic activity of Bay u3405, a thromboxane A2-antagonist, in patients with Dacron aortic grafts: a random controlled clinical trialH Pieters, J P Roodt, P N Badenhorst, et al.
International Journal of Clinical Pharmacology and Therapeutics|August 1, 1995
Reference tables for the intrasubject coefficient of variation in bioequivalence studiesV W Steinijans, R Sauter, D Hauschke, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|June 1, 1996
The efficacy of two bupivacaine hydrochloride injection productsF O Müller, J P Claasen, R Schall, et al.
Pageof 9

Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
Biopharmaceutics & Drug Disposition|August 1, 1994
Relative bioavailability of four controlled-release nifedipine productsR Schall, F O Müller, H K Hundt, et al.
Medicine and Science in Sports and Exercise|April 1, 1991
Metabolic rate, not percent dehydration, predicts rectal temperature in marathon runnersT D Noakes, K H Myburgh, J du Plessis, et al.
International Journal of Clinical Pharmacology and Therapeutics|May 1, 1995
No influence of pantoprazole on the pharmacokinetics of phenytoinM V Middle, F O Müller, R Schall, et al.
British Journal of Clinical Pharmacology|June 1, 1995
Lack of effect of pantoprazole on the pharmacodynamics and pharmacokinetics of warfarinL Duursema, F O Müller, R Schall, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 30, 2016
A world-wide survey and field study in clinical haemostasis laboratories to evaluate FVIII:C activity assay variability of ADYNOVATE and OBIZUR in comparison with ADVATEP L Turecek, S Romeder-Finger, C Apostol, et al.
International Journal of Clinical Pharmacology and Therapeutics|May 1, 1996
No influence of pantoprazole on the pharmacokinetics of phenytoinM V Middle, F O Müller, R Schall, et al.
Arzneimittel-Forschung|November 1, 1995
Relative bioavailability of rifampicin, isoniazid and ethambutol from a combination tablet vs. concomitant administration of a capsule containing rifampicin and a tablet containing isoniazid and ethambutolR Schall, F O Müller, L Duursema, et al.
Thrombosis and Haemostasis|December 20, 1993
Antithrombotic activity of Bay u3405, a thromboxane A2-antagonist, in patients with Dacron aortic grafts: a random controlled clinical trialH Pieters, J P Roodt, P N Badenhorst, et al.
International Journal of Clinical Pharmacology and Therapeutics|August 1, 1995
Reference tables for the intrasubject coefficient of variation in bioequivalence studiesV W Steinijans, R Sauter, D Hauschke, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|June 1, 1996
The efficacy of two bupivacaine hydrochloride injection productsF O Müller, J P Claasen, R Schall, et al.
Pageof 9